Last updated: November 6, 2024
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Common Cold
Allergy
Nasal Obstruction
Treatment
N/AClinical Study ID
NCT06678334
2024-SR-580
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age 18-65 years old;
Patients with chronic rhinitis in the Department of Otorhinolaryngology, the FirstAffiliated Hospital of Nanjing Medical University;
Patients who are willing to provide specimens for free to promote the diagnosis ofchronic rhinitis.
Exclusion
Exclusion Criteria:
Patients received glucocorticoids, immunomodulatory drugs, antihistamines, and othertreatments that may affect the study results within the past 1 month.
Patients with unstable diseases (including severe asthma) and active immune systemdiseases;
Smoking;
Pregnant or lactating women; History of nasal surgery within 5.3 months;
Patients with low compliance and refusing to accept specimen and questionnairecollection
Study Design
Total Participants: 1000
Study Start date:
November 06, 2024
Estimated Completion Date:
December 01, 2032